Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT
Primary result · Mean change in DAS28Result — go to the resultMean difference −0.04 95% CI −0.39 to 0.30Authors' conclusion
Although rheumatic care costs were significantly lower in the app group, total costs and effects of PIC with self-monitoring were not different from usual care in RA patients with LDA.
Study context
- Population
- Adults with established RA (disease duration >2 years) and low disease activity (LDA) (DAS28 <3.2), stable on medication for ≥6 months
- Participants
- 49 vs 53
- Comparison
- Patient-initiated care (PIC) with self-monitoring via smartphone app vs usual care
- Appn = 49
- Usual caren = 53reference
- Primary endpoint
- Cost-effectiveness: change in DAS28 (effect measure) and costs (healthcare resource usage and productivity losses)
- Follow-up
- 12 months
Methodological details12-month
- 12-month
Primary result
Mean change in DAS28
Mean difference
−0.04
95% CI −0.39 to 0.30
Appvs Usual care
mean difference −0.04 (95% CI −0.39 to 0.30)
As reported in the abstract
Further findings
| Outcome | Mean difference (€) (95% CI) | |
|---|---|---|
| Total costs · 12 monthsNot statistically significant | 514 (-€266, €3690) | |
| −2000020004000Difference, € (linear scale) |
Probability app was cost-effective
- At willingness-to-pay threshold of 0 €/point improvement DAS28
- 0.37
- At willingness-to-pay threshold of 50 000 €/point improvement DAS28
- 0.57
Rheumatic care costs
- Significantly lower in the app group
Original publication
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT. Rheumatology (Oxford). Published 17 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →